Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

---
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
Vote:
0 0
Previous More Brands Break the US$1 Million Mark as Lazada Celebrates Partner Growth
Next The Michelin Guide Expands to Phu Quoc, Vietnam

Related News

Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs

Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement

George Clinical Rebrands as Emerald Clinical Trials

CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth

Accely Appoints Michael Lim as Director, Strategy & Growth for Singapore and Southeast Asia

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC

menu
menu